Our company has advanced anticholinergic API synthesis and BFS preparation production technology.
National GMP-certified and high-tech enterprise with a fully integrated “API-Intermediate-Preparation” industrial chain, ensuring strict quality control and supply reliability.
Core manufacturer and leading export base of anticholinergic and emergency rescue APIs in China, supported by advanced synthesis and BFS technology production lines.
Purui Pharmaceutical's factory, founded in 2004, has now developed into an important manufacturing center of the group after years of construction and development. Covering a total area of approximately 120,000 square meters with a cumulative total investment of about 500 million yuan, the factory has built high-standard production workshops, R&D centers and supporting facilities that meet international standards. As a national GMP-certified enterprise, the factory has established a complete production management system, equipped with advanced production processes and strict quality control systems, which can effectively guarantee stable production capacity and product quality. The factory focuses on the independent R&D and production of characteristic APIs such as anticholinergic and emergency rescue types and their high-end preparations, and also undertakes a variety of CDMO business, providing professional production and technical support for global customers.
Henan Purui Pharmaceutical Co., Ltd., a company with nearly two decades of experience in the field of specialty active pharmaceutical ingredients (APIs), recently announced that its anticholinergic and emergency
Leveraging its deep expertise in active pharmaceutical ingredients (APIs), Henan Pury Pharmaceutical Co., Ltd. has achieved remarkable success
In the entire pharmaceutical industry chain of "API-Intermediates-Formulation," pharmaceutical intermediates are a crucial link in ensuring product quality and cost advantages.
As a core manufacturer of anticholinergic and emergency APIs in China, Henan Pury Pharmaceutical Co., Ltd. has continuously
